Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

56 trials with published results (20%)

Research Maturity

168 completed trials (60% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

8.6%

24 terminated out of 278 trials

Success Rate

87.5%

+0.9% vs benchmark

Late-Stage Pipeline

23%

64 trials in Phase 3/4

Results Transparency

33%

56 of 168 completed with results

Key Signals

56 with results88% success24 terminated

Data Visualizations

Phase Distribution

221Total
Not Applicable (98)
Early P 1 (2)
P 1 (31)
P 2 (26)
P 3 (20)
P 4 (44)

Trial Status

Completed168
Unknown40
Terminated24
Not Yet Recruiting15
Recruiting13
Active Not Recruiting8

Trial Success Rate

87.5%

Benchmark: 86.6%

Based on 168 completed trials

Clinical Trials (278)

Showing 20 of 20 trials
NCT07851571Not ApplicableNot Yet RecruitingPrimary

Drone Transport of Deceased-Donor Kidney Grafts Between Two French Hospitals Before Transplantation: a Pilot Safety Study

NCT07763418Phase 1RecruitingPrimary

A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function

NCT00337220Completed

Urine Testing to Detect Kidney Transplant Rejection

NCT06660277Not ApplicableRecruiting

DIALysis With EXpanded Solute Removal

NCT07821788Not Yet RecruitingPrimary

Twice vs Thrice Weekly Hemodialysis: Clinical Outcomes and Quality of Life

NCT07820150Not Yet Recruiting

Hyperparathyroidism and Dialysis Adequacy in Hemodialysis Patients

NCT07817953Not Yet Recruiting

AVF Awareness Among Advanced CKD Patients

NCT07803237Not Yet Recruiting

Predictors of Rapid CKD Progression

NCT03573089Not ApplicableRecruitingPrimary

Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

NCT07426380Phase 1Active Not Recruiting

A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function

NCT07730385Not ApplicableNot Yet RecruitingPrimary

Fish Oil and HDL Function in Patients on Maintenance Hemodialysis

NCT07694271Not ApplicableActive Not Recruiting

Cryotherapy for Reducing Fistula Puncture Pain in Hemodialysis Patients

NCT07716436Not ApplicableCompletedPrimary

Intradialytic Versus Home-Based Exercise in Female Hemodialysis Patients

NCT02910908CompletedPrimary

Characteristics,Treatment Course and Prognosis of Patients Older Than 75 Yrs Old Reaching End Stage Renal Disease (PSPA)

NCT07607041Not Yet RecruitingPrimary

Evolution of Physical Frailty and Patient-Reported Outcome Measures in Kidney Transplant Candidates: A Mixed-Methods Longitudinal Study Protocol

NCT07607197Phase 1RecruitingPrimary

Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)

NCT07612124Not ApplicableCompletedPrimary

Evaluation of the Application of Intelligent Applications in Patients Undergoing Peritoneal Dialysis

NCT05687058Phase 1Active Not RecruitingPrimary

Empagliflozin in ESKD - A Feasibility Study

NCT04876963CompletedPrimary

HOLT-ED: Holter-monitoring in End-stage Renal Disease

NCT06438445Not ApplicableRecruitingPrimary

Effects of Royal Jelly Supplementation in Chronic Kidney Disease

Scroll to load more

Research Network

Activity Timeline